1201935-36-5 Usage
Description
1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is a chemical compound with the molecular formula C10H16N4. It is a pyrazole derivative and contains a methylpiperidine group. 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is significant in medicinal chemistry due to its selective inhibitory activity on certain enzymes, which positions it as a potential candidate for drug development. Its unique structure and properties make it a promising substance for further research and development within the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is used as a research compound for its selective inhibitory activity on certain enzymes. This characteristic makes it valuable in the development of new drugs, particularly those targeting specific enzyme pathways related to various diseases.
Used in Drug Development:
In the field of drug development, 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine serves as a potential lead compound. Its ability to selectively inhibit certain enzymes suggests that it could be instrumental in creating targeted therapies for conditions where these enzymes play a critical role in disease progression.
Used in Medicinal Chemistry Research:
1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is utilized as a subject of study in medicinal chemistry research. Scientists investigate its interactions with biological targets to understand its potential therapeutic applications and to design more effective drugs based on its chemical structure.
Check Digit Verification of cas no
The CAS Registry Mumber 1201935-36-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,9,3 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1201935-36:
(9*1)+(8*2)+(7*0)+(6*1)+(5*9)+(4*3)+(3*5)+(2*3)+(1*6)=115
115 % 10 = 5
So 1201935-36-5 is a valid CAS Registry Number.
1201935-36-5Relevant articles and documents
FGFR Inhibitor compounds and uses thereof
-
, (2021/11/21)
The invention relates to FGFR inhibitor compounds and uses thereof. , The application discloses a compound as shown in a formula (I). A compound, or an optical isomer, a geometric isomer, a tautomer or isomer mixture thereof, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The application further relates to the application of the compound in medicine.
JAK1 SELECTIVE KINASE INHIBITOR
-
, (2020/10/28)
Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as JAK kinase inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (I), and methods of using such compounds or compositions to treat respiratory conditions (e.g., asthma or COPD).
HETEROCYCLIC COMPOUNDS FOR MEDIATING TYROSINE KINASE 2 ACTIVITY
-
, (2021/01/23)
Heterocyclic compounds shown in Formula (I) suitable for inhibiting or regulating the activity of Janus kinase (JAK), particularly tyrosine kinase 2 (TYK2). The compounds are useful for preventing and/or treating relevant JAK-mediated diseases, such as autoimmune diseases, inflammatory diseases, and cancers.
